We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Carl Zeiss Acquires Bio-Rad's Cell Science Division

By Biotechdaily staff writers
Posted on 15 Jun 2004
In a move that will enlarge its microscopy business, Carl Zeiss (Oberkochen, Germany) has acquired the Cell Science Division (Hemel Hempstead, UK) of Bio-Rad Laboratories, Inc. (Hercules, CA, USA). Terms were not disclosed.

This strategic move is part of the ongoing investment in enhancing the application expertise at Carl Zeiss, according to the company. The acquisition is expected to accelerate future advances in confocal and multiphoton microscope instrumentation with Carl Zeiss as the major driving force in the field.

"Today, Carl Zeiss stands for high-end laser scanning microscopes that are benchmark solutions for advanced applications in 3-D microscopy,” said Dr. Ulrich Simon, head of the microscopy business group at Carl Zeiss. "Joining our forces will strengthen our relationship with Zeiss and Bio-Rad customers, and will allow a considerable additional refinement of both companies' worldwide service and support network.”





Related Links:
Carl Zeiss
Bio-Rad

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
All-in-One Molecular System
AIO M160

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
15 Jun 2004  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
15 Jun 2004  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
15 Jun 2004  |   BioResearch